Medical Aspects of Biological Warfare

Item Type:

Publication

Title

Medical Aspects of Biological Warfare

Description

This is an open source text book for military medical educational use.

Source

J. Bozue, C. K. Cote, and P. J. Glass

Date Last Updated (Year-Month-Day)

2018-09-05

Citation

Bozue, J., C. K. Cote, and P. J. Glass. 2018. Medical Aspects of Biological Warfare, Textbooks of military medicine: Office of the Surgeon General, Borden Institute, US Army Medical Department Center and School, Health Readiness Center of Excellence.

Abstract

Contents

Contributors xi

Peer Reviewers xvii

Foreword by The Surgeon General xxi

Preface xxiii

  1. Historical Overview: From Poisoned Darts to Pan-Hazard Preparedness 1 George W. Christopher, Daniel M. Gerstein, Edward M. Ei en, and James W. Martin
  2. Epidemiology of Biowarfare and Bioterrorism 37 Zygmunt F. Dembek, Julie A. Pavlin, Martina Siwek, and Mark G. Kortepeter
  3. Food, Waterborne, and Agricultural Diseases 71 Zygmunt F. Dembek, and Edwin L. Anderson
  4. Consequence Management: The Local and National Response 93 Neal E. Woollen, and Gary W. Carter
  5. Medical Management of Potential Biological Casualties: A Stepwise Approach 109 Theodore J. Cieslak
  6. Anthrax 129 Bret K. Purcell, Christopher K. Cote, Patricia L. Worsham, and Arthur M. Friedlander
  7. Brucellosis 159 Bret K. Purcell, R. Martin Roop II, Arthur M. Friedlander, and David L. Hoover
  8. Glanders 177 Susan L. Welkos, Bridget Carr Gregory, David M. Waag, and Mary N. Burtnick
  9. Melioidosis 223 Paul J. Bre , David DeShazer, and Nicholas J. Vietri
  10. Plague 247 Patricia L. Worsham, Thomas W. McGovern, Nicholas J. Vietri, Arthur M. Friedlander, and Joel Bozue
  11. Tularemia 285 Ma hew J. Hepburn, Todd M. Kijek, Wendy Sammons-Jackson, Arthur M. Friedlander, and
    Zygmunt F. Dembek
  12. Q Fever 305 Christina M. Farris and James E. Samuel
  13. Multidrug-Resistant Bacterial Infections as a Threat to the US Military Health System: 321 Acinetobacter Infections as a Case Study
    Emil Lesho, Luther E. Lindler, Bruno Petruccelli, and Glenn Wortmann
  14. Botulinum Toxin 337 Zygmunt F. Dembek, Leonard A. Smith, Frank J. Lebeda, and Janice M. Rusnak
  15. Clostridium Perfringens Epsilon Toxin 361 Bradley G. Stiles, Gillian Barth, and Michel R. Popo
  16. Ricin 373 Virginia I. Roxas-Duncan, Martha L. Hale, Jon M. Davis, John C. Gorbet, Patricia M. Legler, and
    Leonard M. Smith
  17. Staphylococcal Enterotoxin B and Related Toxins Produced by Staphylococcus Aureus and 403 Streptococcus Pyogenes
    Kamal U. Saikh, Robert G. Ulrich, and Teresa Krakauer
  18. Toxins from Venoms and Poisons 415 Sco A. Weinstein and Julian White
  19. Marine Algal Toxins of Concern as Intentional Contaminants 461 Mark A. Poli and Mark R. Withers
  20. Alphavirus Encephalitides 479 Shelley P. Honnold, Eric C. Mossel, Lesley C. Dupuy, Elaine M. Morazzani, Shannon S. Martin,
    Mary Kate Hart, George V. Ludwig, Michael D. Parker, Jonathan F. Smith, Douglas S. Reed, and
    Pamela J. Glass
  21. Hemorrhagic Fever-Causing Mammarenaviruses 517 Sheli R. Radoshi ky, Jens H. Kuhn, Peter B. Jahrling, and Sina Bavari
  22. Henipaviruses 547 Arnold Park, Sheli R. Radoshi ky, Jens H. Kuhn, and Benhur Lee
  23. Filoviruses 569 Sheli R. Radoshi ky, Sina Bavari, Peter B. Jahrling, and Jens H. Kuhn
  24. Smallpox and Related Orthopoxviruses 615 Arthur J. Go , Sara C. Johnston, Kenny L. Lin, Peter B. Jahrling, John W. Huggins, M. So Ibrahim,
    James V. Lawler, and James W. Martin
  25. Emerging Infectious Diseases and Future Threats 645 Chris A. Whitehouse and Bre Bei el
  26. Laboratory Identi cation of Threats 701 David A. Norwood, Timothy D. Minogue, Randal J. Schoepp, and Mark J. Wolco
  27. Medical Countermeasures 751 Phillip R. Pi man, Elizabeth Brown, and Ma hew S. Chambers
  28. Future Prospects of Vaccines and Antibodies in Biodefense 823 Je rey Froude II, Crystal W. Burke, and Jean-Nicolas Tournier
  29. Aerobiology: History, Development, and Programs 855 Douglas S. Reed, Aysegul Nalca, and Chad J. Roy
  30. Biosafety 869 David E. Harbourt, Catherine L. Wilhelmsen, Kristie M. Yeakle, and Robert J. Hawley
  31. Biological Surety 895 Samuel S. Edwin, Virginia I. Roxas-Duncan, America M. Ceralde, Shelley C. Jorgensen, and Neal E. Woollen
  32. Ethical Issues in the Development of Drugs and Vaccines for Biodefense 915 Arthur O. Anderson, Je rey E. Stephenson, and Bret K. Purcell
Abbreviations and Acronyms xxv
Index xxx

Accessibility

Public domain, chapters downloadable as pdf's